시장보고서

상품코드

1842287

말 인공수정 시장 규모, 점유율, 동향 분석 보고서 : 솔루션별, 말의 몸별, 유통 채널별, 지역별, 부문별 예측(2025-2033년)

Equine Artificial Insemination Market Size, Share & Trends Analysis Report By Solution (Equipment & Consumables, Semen), By Equine (Sports/Racing, Recreation), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말 인공수정 시장 요약

세계 말 인공수정 시장 규모는 2024년에 6억 4,817만 달러로 추정되며 2033년에는 10억 7,733만 달러에 달할 것으로 예상되며, 2025년부터 2033년까지 5.94%의 CAGR로 성장할 것으로 예상됩니다.

이 시장은 고부가가치 번식 및 유전적 개량에 대한 수요 증가, 번식 기술 및 수의학적 전문 지식의 발전, 질병 대책 및 바이오 보안의 효과 등을 배경으로 발전하고 있습니다.

스포츠, 경주, 레저 활동에서 고성능 말에 대한 수요 증가는 시장 성장의 주요 촉진요인입니다. 인공수정을 통해 종마 생산자는 지리적 제약 없이 우수한 씨수말의 유전자를 얻을 수 있어 자손의 품질과 시장 가치를 높일 수 있습니다. 2023년 10월에 발표된 기수클럽의 살아있는 자마 보고서에 따르면, 2022년 1,248마리의 씨수말이 북미에서 2,8,548마리의 자마를 낳았고, 2023년에는 1,8,143마리의 자마를 낳았다고 합니다.

인공수정은 또한 부상이나 질병 감염 등 살아있는 자마와 관련된 위험을 줄여줍니다. 정액의 동결, 보관, 운송의 기술적 진보와 함께 육종가들은 유전 물질을 전 세계적으로 이용할 수 있게 되어 번식 선택의 폭이 넓어졌습니다. 자마의 바람직한 형질을 선택적으로 개선할 수 있는 이 능력은 전 세계 전문 육종가들과 승마 단체들 사이에서 인공수정을 채택하는 데 박차를 가하고 있습니다.

정액 채취, 냉동보관, 생식 호르몬 관리 기술의 향상으로 말의 인공수정 성공률이 눈에 띄게 높아졌습니다. 숙련된 수의사 전문가와 전문 번식 센터가 생겨나면서 번식업자들에게 인공수정은 더욱 친숙하고 효율적인 방법이 되었습니다. 심각 인공수정, 초음파 유도 인공수정 등의 기술은 번식력이 어려운 번식 암말의 수태율을 향상시킵니다. 또한, 인공수정은 번식 프로그램의 스케줄링과 계획을 지원하고, 한 마리의 씨수말에서 여러 마리의 씨수말에게 서비스를 제공할 수 있습니다. 이러한 기술 혁신은 비용을 절감하고 효율성을 높이며 말 사육 산업에서 인공수정의 상업적 매력을 높이고 있습니다. 아래 그림은 인공수정에 사용되는 다양한 기술을 자세히 보여줍니다.

말의 인공수정은 바이오 보안 측면에서 큰 이점이 있어 질병 예방을 중시하는 번식업자들에게 선호되는 선택이 되고 있습니다. 인공수정은 씨수말과 씨암말이 물리적으로 접촉할 필요가 없기 때문에 성병 및 기타 전염성 말 질병을 매개하는 위험을 최소화할 수 있습니다. 또한, 정액 사용 전 정액검사 및 정액처리를 실시하여 가축의 건강상태를 개선할 수 있습니다. 이는 질병 발생이 경제적으로나 유전적으로 큰 손실을 초래할 수 있는 고부가가치 번식 프로그램에 특히 중요합니다. 동물의 건강과 복지에 대한 인식이 높아짐에 따라 안전하고 통제된 번식 방법인 인공수정은 시장의 수요를 지속적으로 강화하고 있습니다.

시장 계통 전망
- 상부 시장
- 보조 시장
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 기회 분석
- 시장 과제 분석
말 인공수정 시장 분석 툴
- 업계 분석 - Porter's Five Forces 분석
- PESTEL 분석
- 규제 프레임워크
- 가격 분석
- 주요 국가의 말 추정 개체수(2024년)

제4장 말 인공수정 시장 : 솔루션 추정·동향 분석

부문 대시보드
말 인공수정 시장 : 솔루션 변동 분석
말 인공수정 시장 규모와 동향 분석(솔루션별, 2021-2033년)
기기와 소모품
정액
- 정상 정액
- 성별 판정 정액
서비스

제5장 말 인공수정 시장 : 말의 몸 추정·동향 분석

부문 대시보드
말 인공수정 시장 : 말의 몸 변동 분석
말 인공수정 시장 규모와 동향 분석(말의 몸별, 2021-2033년)
스포츠/레이스
레크리에이션
기타

제6장 말 인공수정 시장 : 유통 채널 추정·동향 분석

부문 대시보드
말 인공수정 시장 : 유통 채널 변동 분석
말 인공수정 시장 규모와 동향 분석(유통 채널별, 2021-2033년)
- 민간
- 공공

제7장 말 인공수정 시장 : 지역 추정·동향 분석

지역 대시보드
말 인공수정 시장 점유율(지역별, 2024년 및 2033년)
지역 전망
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
- 카타르
- 오만

제8장 경쟁 구도

시장 진입 기업 분류
기업의 시장 포지션 분석/히트맵 분석
기업 개요
- IMV Technologies
- Stallion AI Services
- Zoetis
- NEOGEN Corporation
- Zerlotti Genetics Ltd
- ERC sro
- CVS(UK) Limited.
- HOFFMAN AI BREEDERS INC.
- Nasco
- Continental Genetics, LLC
- MINITUB GMBH
- Sussex Equine Hospital

KSM 25.10.30

Equine Artificial Insemination Market Summary

The global equine artificial insemination market size was estimated at USD 648.17 million in 2024 and is projected to reach USD 1,077.33 million by 2033, growing at a CAGR of 5.94% from 2025 to 2033. The market is advancing, driven by rising demand for high-value breeding and genetic improvement, advancements in reproductive technologies and veterinary expertise, anddisease control and biosecurity benefits.

The growing demand for high-performance horses in sports, racing, and leisure activities is a major market growth driver. Artificial insemination enables breeders to access superior stallion genetics without geographical limitations, improving offspring quality and market value. In 2022, 1,248 stallions bred 28,548 mares in North America, producing 18,143 live foals for 2023, according to the Jockey Club's Live Foal Report released in October 2023.

Artificial insemination also reduces the risks associated with live cover, such as injuries or disease transmission. Along with technological advancements in semen freezing, storage, and shipping, breeders can utilize genetic material globally, expanding breeding options. This ability to selectively improve desirable traits in foals is fueling artificial insemination adoption among professional breeders and equestrian organizations worldwide.

Technological improvements in semen collection, cryopreservation, and reproductive hormone management have significantly enhanced the success rates of equine artificial insemination. The availability of skilled veterinary professionals and specialized reproduction centers has made artificial insemination more accessible and efficient for breeders. Techniques such as deep-horn insemination and ultrasound-guided procedures improve conception rates, even in mares with challenging reproductive histories. Furthermore, artificial insemination supports better scheduling and planning of breeding programs, allowing multiple mares to be serviced from a single stallion. These innovations are reducing costs, increasing efficiency, and boosting the commercial appeal of artificial insemination in the equine breeding industry. The chart below illustrates a detailed description of various technologies used for artificial insemination:

Equine artificial insemination offers substantial biosecurity advantages, making it a preferred choice for breeders concerned about disease prevention. By eliminating the need for physical contact between stallions and mares, artificial insemination minimizes the risk of transmitting sexually transmitted infections and other contagious equine diseases. Processed semen can also be screened and treated before use, ensuring better herd health. This is especially critical for high-value breeding programs, where disease outbreaks could cause significant financial and genetic losses. As awareness of animal health and welfare grows, artificial insemination as a safe and controlled breeding method continues to strengthen its market demand.

Global Equine Artificial Insemination Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global equine artificial insemination market report based on solution, equine, distribution channel, and region:

Solution Outlook (Revenue, USD Million, 2021 - 2033)
Equipment & Consumables
Semen
- Normal Semen
- Sexed Semen
Services
Equine Outlook (Revenue, USD Million, 2021 - 2033)
Sports/Racing
Recreation
Other Type
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Private
Public
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- India
- China
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Equine Artificial Insemination Market Variable Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
3.3. Equine Artificial Insemination Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitution
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal landscape
  - 3.3.2.2. Economic and Social landscape
  - 3.3.2.3. Technological landscape
  - 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Estimated Equine Population by key countries, 2024

Chapter 4. Equine Artificial Insemination Market: Solution Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Equine Artificial Insemination Market: Solution Movement Analysis
4.3. Equine Artificial Insemination Market Size & Trend Analysis, by solution, 2021 to 2033 (USD Million)
4.4. Equipment & Consumables
- 4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Semen
- 4.5.1. Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Normal Semen
  - 4.5.2.1. Normal Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Sexed Semen
  - 4.5.3.1. Sexed Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Services
- 4.6.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Equine Artificial Insemination Market: Equine Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Equine Artificial Insemination Market: Equine Movement Analysis
5.3. Equine Artificial Insemination Market Size & Trend Analysis, by Equine, 2021 to 2033 (USD Million)
5.4. Sports/Racing
- 5.4.1. Sports/Racing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Recreation
- 5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Equine Artificial Insemination Market: By Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Equine Artificial Insemination Market: By Distribution Channel Movement Analysis
6.3. Equine Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 6.3.1. Private
  - 6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Public
  - 6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Equine Artificial Insemination Market: Regional Estimates & Trend Analysis

7.1. Regional Dashboard
7.2. Equine Artificial Insemination Market Share, By Region, 2024 & 2033 (USD Million)
7.3. Regional Outlook
7.4. North America
- 7.4.1. North America Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. U.S. Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Canada Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Mexico Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
- 7.5.1. Europe Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. UK Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Germany Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. France Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Italy Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Spain Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Denmark Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Competitive Scenario
  - 7.5.8.3. Sweden Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. Norway
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Competitive Scenario
  - 7.5.9.3. Norway Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Japan Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. China Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Competitive Scenario
  - 7.6.4.3. India Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Competitive Scenario
  - 7.6.5.3. Australia Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. South Korea
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Competitive Scenario
  - 7.6.6.3. South Korea Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Competitive Scenario
  - 7.6.7.3. Thailand Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Brazil Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Argentina Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Competitive Scenario
  - 7.8.2.3. South Africa Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Competitive Scenario
  - 7.8.3.3. Saudi Arabia Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Competitive Scenario
  - 7.8.4.3. UAE Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Competitive Scenario
  - 7.8.5.3. Kuwait Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.8.6. Qatar
  - 7.8.6.1. Key Country Dynamics
  - 7.8.6.2. Competitive Scenario
  - 7.8.6.3. Kuwait Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
- 7.8.7. Oman
  - 7.8.7.1. Key Country Dynamics
  - 7.8.7.2. Competitive Scenario
  - 7.8.7.3. Kuwait Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
- 8.3.1. IMV Technologies
  - 8.3.1.1. Participant's Overview
  - 8.3.1.2. Financial Performance
  - 8.3.1.3. Product/ Service Benchmarking
  - 8.3.1.4. Strategic Initiatives
- 8.3.2. Stallion AI Services
  - 8.3.2.1. Participant's Overview
  - 8.3.2.2. Financial Performance
  - 8.3.2.3. Product/ Service Benchmarking
  - 8.3.2.4. Strategic Initiatives
- 8.3.3. Zoetis
  - 8.3.3.1. Participant's Overview
  - 8.3.3.2. Financial Performance
  - 8.3.3.3. Product/ Service Benchmarking
  - 8.3.3.4. Strategic Initiatives
- 8.3.4. NEOGEN Corporation
  - 8.3.4.1. Participant's Overview
  - 8.3.4.2. Financial Performance
  - 8.3.4.3. Product/ Service Benchmarking
  - 8.3.4.4. Strategic Initiatives
- 8.3.5. Zerlotti Genetics Ltd
  - 8.3.5.1. Participant's Overview
  - 8.3.5.2. Financial Performance
  - 8.3.5.3. Product/ Service Benchmarking
  - 8.3.5.4. Strategic Initiatives
- 8.3.6. ERC s.r.o.
  - 8.3.6.1. Participant's Overview
  - 8.3.6.2. Financial Performance
  - 8.3.6.3. Product/ Service Benchmarking
  - 8.3.6.4. Strategic Initiatives
- 8.3.7. CVS (UK) Limited.
  - 8.3.7.1. Participant's Overview
  - 8.3.7.2. Financial Performance
  - 8.3.7.3. Product/ Service Benchmarking
  - 8.3.7.4. Strategic Initiatives
- 8.3.8. HOFFMAN A.I. BREEDERS INC.
  - 8.3.8.1. Participant's Overview
  - 8.3.8.2. Financial Performance
  - 8.3.8.3. Product/ Service Benchmarking
  - 8.3.8.4. Strategic Initiatives
- 8.3.9. Nasco
  - 8.3.9.1. Participant's Overview
  - 8.3.9.2. Financial Performance
  - 8.3.9.3. Product/ Service Benchmarking
  - 8.3.9.4. Strategic Initiatives
- 8.3.10. Continental Genetics, LLC
  - 8.3.10.1. Participant's Overview
  - 8.3.10.2. Financial Performance
  - 8.3.10.3. Product/ Service Benchmarking
  - 8.3.10.4. Strategic Initiatives
- 8.3.11. MINITUB GMBH
  - 8.3.11.1. Participant's Overview
  - 8.3.11.2. Financial Performance
  - 8.3.11.3. Product/ Service Benchmarking
  - 8.3.11.4. Strategic Initiatives
- 8.3.12. Sussex Equine Hospital
  - 8.3.12.1. Participant's Overview
  - 8.3.12.2. Financial Performance
  - 8.3.12.3. Product/ Service Benchmarking
  - 8.3.12.4. Strategic Initiatives